Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 May;50 Suppl 3(Suppl 3):III25-30.
doi: 10.1136/gut.50.suppl_3.iii25.

Cyclooxygenase inhibition: between the devil and the deep blue sea

Affiliations
Review

Cyclooxygenase inhibition: between the devil and the deep blue sea

C J Hawkey. Gut. 2002 May.

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) account for more reports of drug related toxicity than any other class of drugs. Their most widely recognised adverse effects are on the gastrointestinal tract. They cause acute erosions and chronic ulcers that result in hospitalisation and death because of ulcer bleeding and perforation. Between them, aspirin and non-aspirin NSAIDs may account for more than half of all episodes of ulcer bleeding and perforation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of COX selectivity assay.
Figure 2
Figure 2
Selectivity ratios of selected drugs. Derived from IC80 data.31
Figure 3
Figure 3
Effect of naproxen 1 g daily and rofecoxib 50 mg daily on ex vivo gastric mucosal prostaglandin synthesis. Volunteers received placebo, naproxen, or rofecoxib for seven days. Twelve standardised gastric mucosal biopsy samples were taken and prostaglandin synthesis stimulated by vortex mixing. Reproduced from Gastroenterology with permission.33
Figure 4
Figure 4
Acute volunteer studies. Lanza grade 2 = one or more erosions. Data derived from Lanza.35, 43
Figure 5
Figure 5
Ulcer development over 12 weeks in patients receiving placebo, rofecoxib 25 mg, rofecoxib 50 mg, or ibuprofen 2.4 g daily. Combined data from two studies covering 1516 patients. Reproduced by permission from Arthritis & Rheumatism.39
Figure 6
Figure 6
Ulcer development in patients receiving celecoxib in endoscopic studies. Reproduced with kind permission of the Journal of the American Medical Association.44

References

    1. Clin Ther. 2000 Apr;22(4):400-10 - PubMed
    1. Gastroenterology. 1999 Oct;117(4):776-83 - PubMed
    1. Pharmacotherapy. 2000 Jul;20(7):741-4 - PubMed
    1. Gastroenterology. 2000 Aug;119(2):521-35 - PubMed
    1. Am J Med. 2000 Aug 15;109(3):201-6 - PubMed

MeSH terms